Effects of different traditional Chinese exercises on pulmonary function in patients with stable chronic obstructive pulmonary disease: a network meta-analysis

被引:3
作者
Liu, Peirong [1 ]
Li, Yongjie [2 ]
Tang, Ding [1 ]
Liu, Gan [1 ]
Zou, Yao [1 ]
Ma, Yong [1 ]
Zheng, Weitao [1 ]
机构
[1] Wuhan Sports Univ, Res Ctr Sports Equipment Engn Technol Hubei Prov, Key Lab Sports Engn Gen Adm Sports China, Wuhan 430079, Peoples R China
[2] Guizhou Hosp, Beijing Jishuitan Hosp, Dept Rehabil Med, Guiyang 550014, Peoples R China
关键词
Chronic obstructive pulmonary disease; Network meta-analysis; Qigong; REHABILITATION; COPD;
D O I
10.1186/s12906-024-04609-9
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
ObjectiveTraditional Chinese exercises (Taichi, Wuqinxi, Liuzijue, and Baduanjin) are considered effective alternative treatments for improving symptoms in the stable phase of COPD. However, the most effective exercise remains unknown. This study compared the effectiveness of different traditional Chinese exercises on pulmonary function in patients with stable chronic obstructive pulmonary disease (COPD) using a network meta-analysis.MethodsFrom database establishment until September 2023, eligible randomized controlled trials (RCTs) were searched. Two reviewers performed the risk of bias assessment of the included studies using the Cochrane Collaboration tool, and the evidence level was suggested using the GRADE system.ResultsFifty-seven studies comprising 4294 patients were included. The results of the network meta-analysis show that Baduanjin was most effective in improving the forced expiratory volume in the first second (FEV1). However, Liuzijue significantly improved the first-second forced vital capacity percentage of expected value (FEV1%) and the ratio of the forced expiratory volume in the first second to the forced vital capacity (FEV1/FVC). The probability ranking results indicated that Liuzijue was the most effective, followed by Baduanjin, Wuqinxi, and Taichi. Subgroup analysis in conjunction with intervention duration revealed that Liuzijue had a significant advantage over other interventions for improving FEV1, FEV1%, and FEV1/FVC within 6 months and improved FEV1% and FEV1/FVC for >= 6 months. Moreover, Subgroup analysis based on baseline pulmonary function revealed that Liuzijue had a significant advantage over other interventions for improving FEV1% within severe and moderate groups. Finally, Subgroup analysis based on the frequency of interventions showed that Liuzijue was still more effective in improving FEV1, FEV1%, and FEV1/FVC in the >= three times one week.ConclusionLiuzijue was more effective than Taichi, Wuqinxi, Liuzijue, and Baduanjin in improving pulmonary function in patients with stable COPD.
引用
收藏
页数:10
相关论文
共 31 条
  • [1] Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
    Agusti, Alvar
    Celli, Bartolome R.
    Criner, Gerard J.
    Halpin, David
    Anzueto, Antonio
    Barnes, Peter
    Bourbeau, Jean
    Han, MeiLan K.
    Martinez, Fernando J.
    de Oca, Maria Montes
    Mortimer, Kevin
    Papi, Alberto
    Pavord, Ian
    Roche, Nicolas
    Salvi, Sundeep
    Sin, Don D.
    Singh, Dave
    Stockley, Robert
    Varela, M. Victorina Lopez
    Wedzicha, Jadwiga A.
    Vogelmeier, Claus F.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (04)
  • [2] The Importance of the Assessment of Pulmonary Function in COPD
    Bailey, Kristina L.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2012, 96 (04) : 745 - +
  • [3] Discriminative Accuracy of FEV1: FVC Thresholds for COPD-Related Hospitalization and Mortality
    Bhatt, Surya P.
    Balte, Pallavi P.
    Schwartz, Joseph E.
    Cassano, Patricia A.
    Couper, David
    Jacobs, David R., Jr.
    Kalhan, Ravi
    O'Connor, George T.
    Yende, Sachin
    Sanders, Jason L.
    Umans, Jason G.
    Dransfield, Mark T.
    Chaves, Paulo H.
    White, Wendy B.
    Oelsner, Elizabeth C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (24): : 2438 - 2447
  • [4] WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial
    Bi, Junjie
    Yang, Wei
    Hao, Ping
    Zhao, Yongmei
    Wei, Dan
    Sun, Yipeng
    Lin, Yuhua
    Sun, Meng
    Chen, Xuan
    Luo, Xuming
    Li, Shanqun
    Zhang, Wei
    Wang, Xiongbiao
    [J]. JMIR MHEALTH AND UHEALTH, 2021, 9 (02):
  • [5] Effectiveness of exercise training in patients with COPD: the role of muscle fatigue
    Burtin, Chris
    Saey, Didier
    Saglam, Melda
    Langer, Daniel
    Gosselink, Rik
    Janssens, Wim
    Decramer, Marc
    Maltais, Francois
    Troosters, Thierry
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (02) : 338 - 344
  • [6] Chronic obstructive pulmonary disease
    Christenson, Stephanie A.
    Smith, Benjamin M.
    Bafadhel, Mona
    Putcha, Nirupama
    [J]. LANCET, 2022, 399 (10342) : 2227 - 2242
  • [7] Clinical guideline highlights for the hospitalist: GOLD COPD update 2024
    Cornelius, Teresa
    [J]. JOURNAL OF HOSPITAL MEDICINE, 2024, 19 (09) : 818 - 820
  • [8] When should we change our clinical practice based on the results of a clinical study? The hierarchy of evidence
    Costantino, Giorgio
    Montano, Nicola
    Casazza, Giovanni
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2015, 10 (06) : 745 - 747
  • [9] Effects of Liuzijue Qigong Posture on Aerodynamics of Phonation in Healthy Volunteers
    Gong, Ting
    Lu, Tao
    Zhang, Yi
    Li, Zhenrui
    Shen, Ao
    Niu, Junhua
    Fang, Rui
    Shan, Chunlei
    [J]. JOURNAL OF VOICE, 2024, 38 (04) : 967e1 - 967e7
  • [10] Benefits of Long-Term Pulmonary Rehabilitation Maintenance Program in Patients with Severe Chronic Obstructive Pulmonary Disease Three-Year Follow-up
    Gueell, Maria-Rosa
    Cejudo, Pilar
    Ortega, Francisco
    Carmen Puy, M.
    Rodriguez-Trigo, Gema
    Ignacio Pijoan, Jose
    Martinez-Indart, Lorea
    Gorostiza, Amaia
    Bdeir, Khaled
    Celli, Bartolome
    Galdiz, Juan B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (05) : 622 - 629